AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2026
Mar 17, 2026
29828_dirs_2026-03-17_32cc44e5-c518-49a2-84c3-a44d1fb9e480.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
Period of Report: 2026-03-16
Reporting Person: Dickinson Andrew D (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-16 | Common Stock | S | 3000 | $144.23 | Disposed | 179191 | Direct |
Footnotes
F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30